Hemispherx Biopharma (HEB) Announces Compliance with NYSE Continued Listing Standards
- Wall Street dragged down by Apple, health stocks
- Unusual 11 Mid-Day Movers 9/29: (ITCI) (ADHD) (MRNS) Higher; (CATB) (AEGR) (DRNA) Lower
- Some Deutsche Bank (DB) Clients Said to Reduce Collateral on Trades
- After Near-Term Outperformance, Barclays Sees Apple (AAPL) Shares Flat from Here
- U.S. economy less sluggish in second quarter; companies investing more
Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.
Hemispherx Biopharma (NYSE: HEB) announced today that, based on a notice received on September 15, 2016 from the New York Stock Exchange, Inc., the Company has regained compliance with the NYSE MKT’s continued listing standards set forth in Part 10 of the NYSE MKT Company Guide.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stein Mart (SMRT) CEO to Resign; Q3 Comps Down 4%
- CBS Corp. (CBS) Receives National Amusements Letter; Will Take Appropriate Action
- Dunkin' Donuts partners with Coca-Cola to enter cold coffee market
Create E-mail Alert Related CategoriesCorporate News
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!